Verified ProfileEN

Hezhi Huashou (Bozhou) Pharmaceutical Co., Ltd.

Order verification — $199

Manufacturing · Other Food Manufacturing

Verification dossier

Hezhi Huashou (Bozhou) Pharmaceutical Co., Ltd. is a Chinese company based in Bozhou, Anhui. The company operates in the other food manufacturing sector, within the broader manufacturing industry. Established 2021, the company has been operating for 5 years.

Sinolinks tracks Hezhi Huashou (Bozhou) Pharmaceutical Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed items: Drug production; Drug wholesale; Drug retail; Class II medical device production; Food production; Food sales; Health food production; Disinfectant production (excluding hazardous chemicals); Disinfectant sales; Production and sales of sanitary materials and disposable medical supplies. General items: Class I medical device production; Class I medical device sales; Class II medical device sales; Health food (pre-packaged) sales; Disinfectant sales (excluding hazardous chemicals); Sales of sanitary materials and disposable medical supplies; Primary processing of edible agricultural products; Sales of agricultural and sideline products; Purchase of primary agricultural products.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review